Search clinical trials for: Rituximab (Rituxan)
Total 3345 results
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
National Cancer Institute (NCI)TerminatedStage III Grade 1 Follicular Lymphoma | Stage III Grade 2 Follicular Lymphoma | Stage III Grade 3 Follicular Lymphoma | Stage IV Grade 1 Follicular Lymphoma | Stage IV Grade 2 Follicular Lymphoma | Stage IV Grade 3 Follicular LymphomaUnited States
-
National Institute of Allergy and Infectious Diseases...GlaxoSmithKline; PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network...Active, not recruitingNephrotic Syndrome | Membranous NephropathyUnited States, Canada
-
University of California, DavisCelgeneActive, not recruiting
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
SCRI Development Innovations, LLCGenentech, Inc.CompletedLymphoma, FollicularUnited States
-
Biointegrator LLCTerminatedRheumatoid ArthritisRussian Federation
-
Merck Sharp & Dohme LLCRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaPoland, Turkey, Denmark, Singapore, Hungary, Hong Kong, Chile, Malaysia, Brazil, Guatemala, China, Taiwan, South Africa, Colombia, United States, Ukraine, Australia, Mexico
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, France, Spain, Malaysia, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Belgium, Turkey, Czechia
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AbbVieRecruitingMantle Cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMantle Cell Lymphoma | Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingLymphomatoid Granulomatosis | Non-Hodgkins Lymphoma | Lymphoproliferative Disorder | Granulomatosis, LymphomatoidUnited States
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Hoffmann-La RocheCompletedA Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.Lymphocytic Leukemia, ChronicUnited Kingdom
-
Case Comprehensive Cancer CenterTerminatedPrimary Central Nervous System Non-Hodgkin LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminated
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); BayerCompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
James RubensteinGenentech, Inc.; CelgeneCompletedIntraocular Lymphoma | Recurrent/Refractory CNSUnited States
-
Gilead SciencesTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
University of Kansas Medical CenterCephalonCompleted
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
University of WashingtonGenentech, Inc.CompletedDiabetic Nephropathies | Kidney Failure, Chronic | Glomerulonephritis, IGA | Hypertension, Renal
-
CelgeneActive, not recruitingNeoplasmsUnited States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
-
Fred Hutchinson Cancer CenterTerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | KSHV-associated Multicentric Castleman DiseaseUganda
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Recurrent CancerUnited States
-
AbbVieI-Mab Biopharma Co. Ltd.CompletedLymphoma | Solid TumorUnited States, China
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Mayo ClinicCelgene CorporationCompletedIgG4-related Disease | Retroperitoneal Fibrosis | Autoimmune Pancreatitis | IgG4-related Sclerosing Cholangitis | Immunoglobulin G Subclass 4 Related DiseaseUnited States
-
Hoffmann-La RocheGenentech, Inc.CompletedPemphigus VulgarisUnited States, Spain, Israel, Australia, France, Argentina, Canada, Turkey, Germany, Brazil, Italy, Ukraine
-
Swiss Group for Clinical Cancer ResearchCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...CompletedMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisUnited States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of KentuckyCephalonWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Lee, StephanieNational Cancer Institute (NCI)CompletedSystemic Scleroderma | Graft Versus Host DiseaseUnited States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedFollicular Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular LymphomaUnited States
-
Hackensack Meridian HealthActive, not recruitingMantle Cell LymphomaUnited States
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Spain, China, Belgium, France, United Kingdom, Israel, Turkey, Russian Federation, Italy, Brazil, Czechia, Portugal, Germany, Japan, Poland, Puerto Rico
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
German CLL Study GroupUniversity of CologneCompletedChronic Lymphocytic LeukemiaGermany
-
Georgetown UniversityCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesTerminatedB-cell Chronic Lymphocytic Leukemia (CLL) With 17p DeletionUnited States, Spain, Denmark, Belgium, Australia, Poland, Romania, Czechia, Italy, France, Hungary, Austria, Portugal, United Kingdom